BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 30589115)

  • 1. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein corona: a new approach for nanomedicine design.
    Nguyen VH; Lee BJ
    Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines.
    Aliyandi A; Zuhorn IS; Salvati A
    Front Bioeng Biotechnol; 2020; 8():599454. PubMed ID: 33363128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
    Hamad-Schifferli K
    Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress and application opportunities of nanoparticle-protein corona complexes.
    Huang W; Xiao G; Zhang Y; Min W
    Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
    Nienhaus K; Nienhaus GU
    Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona.
    Caracciolo G; Farokhzad OC; Mahmoudi M
    Trends Biotechnol; 2017 Mar; 35(3):257-264. PubMed ID: 27663778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Nanomedicine Development Based on Specific Opsonization of Human Cancer Patient-Personalized Protein Coronas.
    Ren J; Cai R; Wang J; Daniyal M; Baimanov D; Liu Y; Yin D; Liu Y; Miao Q; Zhao Y; Chen C
    Nano Lett; 2019 Jul; 19(7):4692-4701. PubMed ID: 31244235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
    Pustulka SM; Ling K; Pish SL; Champion JA
    ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
    Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
    Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
    Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
    ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and biological effects of protein corona for food-related nanoparticles.
    Cui G; Su W; Tan M
    Compr Rev Food Sci Food Saf; 2022 Mar; 21(2):2002-2031. PubMed ID: 34716644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine design.
    Liu K; Salvati A; Sabirsh A
    Nanoscale; 2022 Feb; 14(6):2136-2154. PubMed ID: 35103268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An In Situ Investigation of the Protein Corona Formation Kinetics of Single Nanomedicine Carriers by Self-Regulated Electrochemiluminescence Microscopy.
    Xing Z; Gou X; Jiang LP; Zhu JJ; Ma C
    Angew Chem Int Ed Engl; 2023 Sep; 62(39):e202308950. PubMed ID: 37553293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.